A decision is expected to be made in 2018/19 on the sensitivity threshold for the faecal immunochemical test (FIT) on its introduction to the bowel cancer screening programme.<\/p>
<\/p>
NHS England remains committed to the implementation of FIT testing within the NHS Bowel Cancer Screening Programme from 2018. During 2018, NHS England will finalise a number of practical steps to ensure when FIT is implemented it is sustainable. These steps include: working with Public Health England who will be ensuring that the practical arrangements for managing the production and distribution of FIT kits are in place and working with local providers to ensure sufficient workforce capacity is in place to deliver FIT and save lives.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-02-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-02-28T14:45:19.58Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-02-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Bowel Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether a decision has been reached on the sensitivity threshold for the faecal immunochemical test when it is introduced into the bowel cancer screening programme due to be implemented in April 2018; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3968", "label" : {"_value" : "Biography information for Stephen Lloyd"} } , "tablingMemberConstituency" : {"_value" : "Eastbourne"} , "tablingMemberPrinted" : [{"_value" : "Stephen Lloyd"} ], "uin" : "129172"} , {"_about" : "http://data.parliament.uk/resources/845539", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/845539/answer", "answerText" : {"_value" : "
Public Health England has, on behalf of the five bowel cancer screening hubs in England, led on the procurement of the kit to support the implementation of the faecal immunochemical test in the bowel cancer screening programme in England.<\/p>
<\/p>
Work is now progressing on the process to complete the procurement requirements in order to allow delivery of the kit and other aspects of the service related to the kit.<\/p>
<\/p>
The supplier will be announced once agreement is in place following the completion of the procurement process in spring 2018.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-02-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-02-28T13:08:31.98Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-02-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Bowel Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the decision on the preferred supplier for the faecal immunochemical test kit tender award within the bowel cancer screening programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4656", "label" : {"_value" : "Biography information for Layla Moran"} } , "tablingMemberConstituency" : {"_value" : "Oxford West and Abingdon"} , "tablingMemberPrinted" : [{"_value" : "Layla Moran"} ], "uin" : "128511"} , {"_about" : "http://data.parliament.uk/resources/845652", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/845652/answer", "answerText" : {"_value" : "
The commissioning of services for people diagnosed with Lynch Syndrome, including surveillance, generally sits with clinical commissioning groups (CCGs). CCGs are best placed to commission services to meet the needs of local populations, taking into account the best available evidence.<\/p>
<\/p>
Testing for Lynch syndrome in people with colorectal cancer is targeted using criteria based on family history and age of cancer onset to determine people at higher risk. New National Institute for Health and Care Excellence (NICE) diagnostic guidance recommends extending this offer to all people with colorectal cancer when they are first diagnosed. Offering tests to all people with colorectal cancer will need to be considered by NHS England as part of its service development process.<\/p>
<\/p>
Each year, a number of new drugs, medical devices, tests and treatments in specialised services are put forward to NHS England. The promising proposals are considered by experts in the field, including doctors, public health experts and lay people. These groups, established by NHS England, are known as Clinical Reference Groups (CRGs). The CRGs make detailed assessments of the new treatments, tests and devices through Policy Working Groups and make recommendations on their potential adoption in the NHS.<\/p>
<\/p>
The Medical Genetics CRG will consider the NICE diagnostic guidance and have been asked to submit a Preliminary Policy Proposal and to identify a Clinical Lead to oversee the development of the proposal.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-02-28", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "128627"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-02-28T13:11:28.05Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-02-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Bowel Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps the Government is taking to ensure that funding is appropriately allocated to test all people with bowel cancer for molecular features of Lynch syndrome in accordance with NICE guidance, DG27, published in February 2017.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4656", "label" : {"_value" : "Biography information for Layla Moran"} } , "tablingMemberConstituency" : {"_value" : "Oxford West and Abingdon"} , "tablingMemberPrinted" : [{"_value" : "Layla Moran"} ], "uin" : "128624"} , {"_about" : "http://data.parliament.uk/resources/845655", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/845655/answer", "answerText" : {"_value" : "
The commissioning of services for people diagnosed with Lynch Syndrome, including surveillance, generally sits with clinical commissioning groups (CCGs). CCGs are best placed to commission services to meet the needs of local populations, taking into account the best available evidence.<\/p>
<\/p>
Testing for Lynch syndrome in people with colorectal cancer is targeted using criteria based on family history and age of cancer onset to determine people at higher risk. New National Institute for Health and Care Excellence (NICE) diagnostic guidance recommends extending this offer to all people with colorectal cancer when they are first diagnosed. Offering tests to all people with colorectal cancer will need to be considered by NHS England as part of its service development process.<\/p>
<\/p>
Each year, a number of new drugs, medical devices, tests and treatments in specialised services are put forward to NHS England. The promising proposals are considered by experts in the field, including doctors, public health experts and lay people. These groups, established by NHS England, are known as Clinical Reference Groups (CRGs). The CRGs make detailed assessments of the new treatments, tests and devices through Policy Working Groups and make recommendations on their potential adoption in the NHS.<\/p>
<\/p>
The Medical Genetics CRG will consider the NICE diagnostic guidance and have been asked to submit a Preliminary Policy Proposal and to identify a Clinical Lead to oversee the development of the proposal.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-02-28", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "128624"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-02-28T13:11:28.097Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-02-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Bowel Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, which body is responsible for the governance and funding of testing for molecular features of Lynch syndrome in all people diagnosed with bowel cancer in accordance with NICE guidance, DG27, published in February 2017; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4656", "label" : {"_value" : "Biography information for Layla Moran"} } , "tablingMemberConstituency" : {"_value" : "Oxford West and Abingdon"} , "tablingMemberPrinted" : [{"_value" : "Layla Moran"} ], "uin" : "128627"} , {"_about" : "http://data.parliament.uk/resources/839266", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/839266/answer", "answerText" : {"_value" : "
NHS England remains committed to the implementation of Faecal Immunochemical Test (FIT) within the NHS Bowel Cancer Screening Programme from 2018.<\/p>
<\/p>
During 2018, NHS England will finalise a number of practical steps to ensure that when Faecal Immunochemical Test is implemented, it is sustainable. This includes working with Public Health England, who will be ensuring that the practical arrangements for managing the production and distribution of FIT kits are in place, and working with local providers to ensure sufficient workforce capacity is in place to deliver FIT and save lives. These practical steps will enable NHS England to confirm the specific date in 2018 when FIT will replace Faecal Occult Blood testing.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-02-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-02-23T12:55:43.563Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-02-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Bowel Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the timescale is for the introduction of the Faecal Immunochemical Test to the bowel screening programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1491", "label" : {"_value" : "Biography information for Kerry McCarthy"} } , "tablingMemberConstituency" : {"_value" : "Bristol East"} , "tablingMemberPrinted" : [{"_value" : "Kerry McCarthy"} ], "uin" : "127820"} , {"_about" : "http://data.parliament.uk/resources/828024", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/828024/answer", "answerText" : {"_value" : "
Using existing evidence and modelling techniques the United Kingdom National Screening Committee (UKNSC) is currently consulting on changes to the current bowel screening programme - whether bowel scope and Faecal Immunochemical Testing (FIT) can be offered as a combination or if FIT is robust enough to be the primary screen test from the age of 50 years.<\/p>
<\/p>
The three month consultation closes on 7 April with a recommendation at a subsequent meeting. Information about the consultation and how to participate is available at:<\/p>